Summit Therapeutics Employee Directory

Summit Therapeutics corporate office is located in Rosemary Lane, Cambridge, Cambridgeshire, CB1 3LQ, United Kingdom and has 1-10 employees.

Employees by Department

Departments

Number of employees

Operations

5

Engineering & Technical

3

Medical & Health

2

Sales

1

Human Resources

1

Key Employees of Summit Therapeutics

Summit Therapeutics Global Presence

globalPresence illustration
North America11-50
Europe1-10

Index of contact profiles from Summit Therapeutics

Hundreds of professionals searching for Summit Therapeutics have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at Summit Therapeutics

Explore people who held key positions, contributed to Summit Therapeutics's success, and advanced their careers.

  1. Owner and Consultant at Clinical Research Conc...

    Worked as Senior Manager Clinical Site Partner

    at Summit Therapeutics

    email Kimberly Wilkinson Email direct Kimberly Wilkinson Direct

Explore More

People from Similar Companies in the Manufacturing Industry Located in United Kingdom

Frequently Asked Questions Regarding Summit Therapeutics Employees

How many employees does Summit Therapeutics have?
Summit Therapeutics has 1-10 employees
Who are Summit Therapeutics key employees?
Some of Summit Therapeutics key employees are Hugh Wang, Cathy Duong, Josh Chong, Nrupali Gandhi, Jianling Li
Where is Summit Therapeutics located?
Summit Therapeutics’s headquarters are located at Rosemary Lane, Cambridge, Cambridgeshire, CB1 3LQ, United Kingdom
How do I contact Summit Therapeutics?
Summit Therapeutics Contact Info: Phone number: +44 1235443939 Website: www.summitplc.com
What does Summit Therapeutics do?

Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on the discovery, development, and commercialization of medicinal therapies intended to resolve serious unmet medical needs for cancer patients. The company is developing ivonescimab, a novel investigational bispecific antibody that combines PD-1 blockade with VEGF blocking to... provide immunotherapy and anti-angiogenesis effects. Through a partnership with Akeso, Inc., Summit is conducting Phase 3 clinical trials for ivonescimab, specifically targeting non-small cell lung cancer and other solid tumors. Its operations serve oncology patients, physicians, and caregivers across license territories including the United States, Canada, Europe, Japan, Latin America, the Middle East, and Africa.Read More

Is Summit Therapeutics a public company?
Summit Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Summit Therapeutics Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.